-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Marker Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q1 2019 to Q1 2023.
- Marker Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Mar 2023 was $1.16M, a 37.9% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)